Concepts (272)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Nicotine | 1 | 2026 | 117 | 0.890 |
Why?
|
| Electronic Nicotine Delivery Systems | 1 | 2026 | 59 | 0.890 |
Why?
|
| Smoking Cessation | 1 | 2026 | 191 | 0.840 |
Why?
|
| Oxygen | 2 | 2015 | 551 | 0.630 |
Why?
|
| Community Health Centers | 1 | 2019 | 35 | 0.600 |
Why?
|
| Photoperiod | 1 | 2018 | 19 | 0.570 |
Why?
|
| Community Health Workers | 1 | 2019 | 79 | 0.570 |
Why?
|
| Periodicity | 1 | 2018 | 47 | 0.570 |
Why?
|
| Transcriptional Activation | 2 | 2024 | 419 | 0.550 |
Why?
|
| Photoplethysmography | 2 | 2015 | 9 | 0.540 |
Why?
|
| 5-alpha Reductase Inhibitors | 1 | 2017 | 14 | 0.530 |
Why?
|
| Exercise | 2 | 2015 | 859 | 0.520 |
Why?
|
| Decision Support Techniques | 2 | 2011 | 295 | 0.500 |
Why?
|
| Models, Genetic | 1 | 2018 | 747 | 0.460 |
Why?
|
| Computer Simulation | 1 | 2018 | 676 | 0.450 |
Why?
|
| X-Box Binding Protein 1 | 3 | 2020 | 32 | 0.450 |
Why?
|
| Pulse Wave Analysis | 1 | 2015 | 53 | 0.440 |
Why?
|
| T-Lymphocytes, Regulatory | 3 | 2026 | 233 | 0.440 |
Why?
|
| Stroke Volume | 2 | 2015 | 537 | 0.440 |
Why?
|
| Uncertainty | 2 | 2012 | 96 | 0.430 |
Why?
|
| Biomedical Engineering | 1 | 2014 | 21 | 0.430 |
Why?
|
| Monitoring, Ambulatory | 2 | 2014 | 55 | 0.420 |
Why?
|
| Attitude of Health Personnel | 1 | 2019 | 701 | 0.400 |
Why?
|
| Nuclear Receptor Coactivator 3 | 2 | 2026 | 258 | 0.390 |
Why?
|
| Primary Health Care | 1 | 2019 | 769 | 0.390 |
Why?
|
| Health Information Management | 1 | 2012 | 5 | 0.390 |
Why?
|
| Epidemics | 1 | 2012 | 57 | 0.370 |
Why?
|
| Physiology | 1 | 2012 | 12 | 0.360 |
Why?
|
| Games, Experimental | 1 | 2011 | 7 | 0.340 |
Why?
|
| Health Policy | 1 | 2012 | 223 | 0.320 |
Why?
|
| Wireless Technology | 1 | 2010 | 13 | 0.320 |
Why?
|
| Depression | 1 | 2017 | 1318 | 0.280 |
Why?
|
| Circadian Clocks | 2 | 2020 | 86 | 0.270 |
Why?
|
| Circadian Rhythm | 4 | 2020 | 315 | 0.250 |
Why?
|
| Tuberculosis | 1 | 2012 | 553 | 0.250 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2011 | 495 | 0.230 |
Why?
|
| Liver | 4 | 2022 | 1797 | 0.220 |
Why?
|
| Ribonucleotides | 1 | 2024 | 31 | 0.210 |
Why?
|
| Heart Failure | 3 | 2015 | 2320 | 0.210 |
Why?
|
| RNA Stability | 1 | 2024 | 75 | 0.210 |
Why?
|
| Homeostasis | 2 | 2020 | 715 | 0.210 |
Why?
|
| Gene Expression Regulation | 4 | 2020 | 2354 | 0.200 |
Why?
|
| Proto-Oncogene Proteins c-myc | 1 | 2024 | 188 | 0.200 |
Why?
|
| NF-E2-Related Factor 2 | 1 | 2024 | 134 | 0.200 |
Why?
|
| Biological Transport | 2 | 2015 | 331 | 0.190 |
Why?
|
| Mice | 12 | 2026 | 18197 | 0.190 |
Why?
|
| Fibroblasts | 2 | 2024 | 859 | 0.190 |
Why?
|
| Prostatic Neoplasms | 1 | 2011 | 1414 | 0.190 |
Why?
|
| Gene Editing | 1 | 2025 | 227 | 0.190 |
Why?
|
| Humans | 36 | 2026 | 130483 | 0.190 |
Why?
|
| CRISPR-Cas Systems | 1 | 2025 | 318 | 0.180 |
Why?
|
| Mammary Neoplasms, Animal | 1 | 2023 | 135 | 0.180 |
Why?
|
| Transcription, Genetic | 4 | 2020 | 1391 | 0.180 |
Why?
|
| Breast Neoplasms | 2 | 2024 | 2603 | 0.170 |
Why?
|
| Diabetes Mellitus | 1 | 2009 | 891 | 0.170 |
Why?
|
| Membrane Fluidity | 1 | 2020 | 17 | 0.170 |
Why?
|
| Cyclohexanones | 1 | 2020 | 18 | 0.170 |
Why?
|
| HIV Infections | 1 | 2012 | 2013 | 0.160 |
Why?
|
| Phospholipids | 1 | 2020 | 100 | 0.160 |
Why?
|
| Ultradian Rhythm | 1 | 2020 | 1 | 0.160 |
Why?
|
| Ventricular Remodeling | 1 | 2020 | 154 | 0.160 |
Why?
|
| Biological Clocks | 1 | 2020 | 28 | 0.160 |
Why?
|
| Receptors, Adrenergic, beta | 1 | 2020 | 45 | 0.160 |
Why?
|
| Animals | 14 | 2026 | 33862 | 0.160 |
Why?
|
| Receptors, Steroid | 1 | 2020 | 173 | 0.150 |
Why?
|
| Oxidative Stress | 1 | 2024 | 796 | 0.150 |
Why?
|
| Myocardium | 2 | 2024 | 859 | 0.150 |
Why?
|
| Pyridines | 1 | 2020 | 260 | 0.150 |
Why?
|
| Lipid Metabolism | 1 | 2022 | 373 | 0.150 |
Why?
|
| Cell Culture Techniques | 1 | 2020 | 277 | 0.140 |
Why?
|
| Unfolded Protein Response | 1 | 2017 | 64 | 0.130 |
Why?
|
| Oxidoreductases | 1 | 2017 | 105 | 0.130 |
Why?
|
| Self-Injurious Behavior | 1 | 2017 | 64 | 0.120 |
Why?
|
| Mice, Knockout | 5 | 2026 | 3818 | 0.120 |
Why?
|
| Endoplasmic Reticulum Stress | 1 | 2017 | 125 | 0.120 |
Why?
|
| Organ Specificity | 2 | 2020 | 397 | 0.120 |
Why?
|
| Shc Signaling Adaptor Proteins | 1 | 2015 | 10 | 0.120 |
Why?
|
| Nuclear Receptor Subfamily 1, Group D, Member 1 | 1 | 2015 | 23 | 0.120 |
Why?
|
| Non-alcoholic Fatty Liver Disease | 1 | 2020 | 409 | 0.110 |
Why?
|
| History, 20th Century | 2 | 2014 | 360 | 0.110 |
Why?
|
| Portraits as Topic | 1 | 2014 | 2 | 0.110 |
Why?
|
| Healthy Volunteers | 1 | 2015 | 150 | 0.110 |
Why?
|
| Suicide | 1 | 2017 | 198 | 0.110 |
Why?
|
| Disease Management | 2 | 2015 | 559 | 0.110 |
Why?
|
| Signal Transduction | 2 | 2024 | 4678 | 0.100 |
Why?
|
| Vascular Diseases | 1 | 2015 | 153 | 0.100 |
Why?
|
| Ethics, Medical | 2 | 1987 | 398 | 0.100 |
Why?
|
| History, 21st Century | 1 | 2014 | 256 | 0.100 |
Why?
|
| Myocardial Infarction | 1 | 2020 | 998 | 0.100 |
Why?
|
| Monitoring, Physiologic | 1 | 2015 | 372 | 0.100 |
Why?
|
| Decision Theory | 1 | 2012 | 2 | 0.100 |
Why?
|
| Male | 14 | 2026 | 64563 | 0.100 |
Why?
|
| Decision Support Systems, Clinical | 1 | 2015 | 205 | 0.090 |
Why?
|
| Policy Making | 1 | 2012 | 59 | 0.090 |
Why?
|
| Heart Rate | 2 | 2015 | 574 | 0.090 |
Why?
|
| Attitude to Health | 1 | 2014 | 244 | 0.090 |
Why?
|
| Self Care | 1 | 2014 | 226 | 0.090 |
Why?
|
| Chromatin | 1 | 2015 | 502 | 0.090 |
Why?
|
| Oxyhemoglobins | 1 | 2012 | 25 | 0.090 |
Why?
|
| Algorithms | 1 | 2018 | 1681 | 0.090 |
Why?
|
| Ambulatory Care | 2 | 1997 | 400 | 0.090 |
Why?
|
| Glucose | 1 | 2015 | 855 | 0.080 |
Why?
|
| Computers | 1 | 2011 | 67 | 0.080 |
Why?
|
| Fibrosis | 2 | 2024 | 419 | 0.080 |
Why?
|
| Validation Studies as Topic | 1 | 2010 | 11 | 0.080 |
Why?
|
| Hemoglobins | 1 | 2012 | 287 | 0.080 |
Why?
|
| Models, Theoretical | 1 | 2012 | 363 | 0.080 |
Why?
|
| Pericarditis | 1 | 1990 | 43 | 0.080 |
Why?
|
| Cardiac Output | 2 | 2010 | 152 | 0.080 |
Why?
|
| Computers, Handheld | 1 | 2010 | 32 | 0.080 |
Why?
|
| Focus Groups | 1 | 2011 | 232 | 0.080 |
Why?
|
| Physicians | 2 | 1987 | 634 | 0.080 |
Why?
|
| Burns | 2 | 1987 | 91 | 0.070 |
Why?
|
| Acquired Immunodeficiency Syndrome | 1 | 1990 | 217 | 0.070 |
Why?
|
| Health Education | 1 | 2011 | 226 | 0.070 |
Why?
|
| Reflex, Pupillary | 1 | 1989 | 16 | 0.070 |
Why?
|
| Pellagra | 1 | 1988 | 1 | 0.070 |
Why?
|
| Mice, Inbred C57BL | 3 | 2026 | 4697 | 0.070 |
Why?
|
| Pupil | 1 | 1989 | 45 | 0.070 |
Why?
|
| Probability | 1 | 2009 | 306 | 0.070 |
Why?
|
| Global Health | 1 | 2012 | 626 | 0.070 |
Why?
|
| Cell Line, Tumor | 2 | 2026 | 3720 | 0.070 |
Why?
|
| Hospitals, Veterans | 1 | 1989 | 345 | 0.070 |
Why?
|
| Time Factors | 3 | 2020 | 6203 | 0.060 |
Why?
|
| Pelvic Inflammatory Disease | 1 | 1986 | 3 | 0.060 |
Why?
|
| Gas Gangrene | 1 | 1986 | 6 | 0.060 |
Why?
|
| Adult | 10 | 2015 | 31138 | 0.060 |
Why?
|
| Drug Industry | 1 | 1985 | 48 | 0.060 |
Why?
|
| Education, Medical | 1 | 1989 | 291 | 0.060 |
Why?
|
| Lymphocytes, Tumor-Infiltrating | 1 | 2026 | 144 | 0.060 |
Why?
|
| Laparotomy | 1 | 1986 | 138 | 0.050 |
Why?
|
| Electrocardiography | 1 | 2010 | 974 | 0.050 |
Why?
|
| Blood Glucose | 1 | 2009 | 1108 | 0.050 |
Why?
|
| Zoonoses | 1 | 1984 | 54 | 0.050 |
Why?
|
| Heme Oxygenase-1 | 1 | 2024 | 33 | 0.050 |
Why?
|
| Orthomyxoviridae Infections | 1 | 1984 | 56 | 0.050 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2011 | 908 | 0.050 |
Why?
|
| Patient Education as Topic | 1 | 1987 | 456 | 0.050 |
Why?
|
| Physician-Patient Relations | 1 | 1987 | 435 | 0.050 |
Why?
|
| Mice, Transgenic | 2 | 2020 | 2342 | 0.050 |
Why?
|
| Female | 7 | 2026 | 70322 | 0.050 |
Why?
|
| Cell Differentiation | 2 | 2020 | 1927 | 0.050 |
Why?
|
| Cell Survival | 1 | 2024 | 837 | 0.040 |
Why?
|
| Ligands | 1 | 2023 | 486 | 0.040 |
Why?
|
| Tamoxifen | 1 | 2023 | 349 | 0.040 |
Why?
|
| Tumor Microenvironment | 1 | 2026 | 699 | 0.040 |
Why?
|
| Swine | 1 | 1984 | 1184 | 0.040 |
Why?
|
| Heart Function Tests | 1 | 2020 | 49 | 0.040 |
Why?
|
| RAW 264.7 Cells | 1 | 2020 | 47 | 0.040 |
Why?
|
| Quality of Life | 1 | 2011 | 2072 | 0.040 |
Why?
|
| Mammals | 1 | 2022 | 255 | 0.040 |
Why?
|
| Urethritis | 1 | 1980 | 1 | 0.040 |
Why?
|
| Leucomycins | 1 | 1980 | 2 | 0.040 |
Why?
|
| Surveys and Questionnaires | 1 | 2011 | 4004 | 0.040 |
Why?
|
| Gonorrhea | 1 | 1980 | 43 | 0.040 |
Why?
|
| Adrenergic Agents | 1 | 2020 | 11 | 0.040 |
Why?
|
| Electric Conductivity | 1 | 2020 | 80 | 0.040 |
Why?
|
| Typhoid Fever | 1 | 1979 | 18 | 0.040 |
Why?
|
| Bioreactors | 1 | 2020 | 43 | 0.040 |
Why?
|
| Aged, 80 and over | 1 | 2011 | 6783 | 0.040 |
Why?
|
| Adipogenesis | 1 | 2020 | 80 | 0.040 |
Why?
|
| Epinephrine | 1 | 2020 | 143 | 0.040 |
Why?
|
| Tissue Scaffolds | 1 | 2020 | 82 | 0.040 |
Why?
|
| Protein Isoforms | 1 | 2020 | 419 | 0.040 |
Why?
|
| Lipids | 1 | 2022 | 563 | 0.030 |
Why?
|
| Tissue Engineering | 1 | 2020 | 153 | 0.030 |
Why?
|
| Rats | 1 | 2024 | 3396 | 0.030 |
Why?
|
| Hypoxia | 1 | 2020 | 247 | 0.030 |
Why?
|
| Fatty Acids | 1 | 2020 | 376 | 0.030 |
Why?
|
| Kinetics | 1 | 2020 | 1087 | 0.030 |
Why?
|
| Immunotherapy, Adoptive | 1 | 2025 | 948 | 0.030 |
Why?
|
| Aged | 4 | 2011 | 20901 | 0.030 |
Why?
|
| Apoptosis | 1 | 2024 | 1842 | 0.030 |
Why?
|
| RNA | 1 | 2020 | 520 | 0.030 |
Why?
|
| Gene Regulatory Networks | 1 | 2020 | 384 | 0.030 |
Why?
|
| Energy Metabolism | 1 | 2022 | 797 | 0.030 |
Why?
|
| Outpatient Clinics, Hospital | 1 | 1997 | 72 | 0.030 |
Why?
|
| Efficiency, Organizational | 1 | 1997 | 55 | 0.030 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2024 | 2028 | 0.030 |
Why?
|
| Macrophages | 1 | 2020 | 655 | 0.030 |
Why?
|
| Glucokinase | 1 | 2015 | 13 | 0.030 |
Why?
|
| Nuclear Receptor Subfamily 1, Group F, Member 1 | 1 | 2015 | 17 | 0.030 |
Why?
|
| Anti-Bacterial Agents | 2 | 1987 | 2549 | 0.030 |
Why?
|
| Health Resources | 1 | 1997 | 126 | 0.030 |
Why?
|
| ARNTL Transcription Factors | 1 | 2015 | 46 | 0.030 |
Why?
|
| Forearm | 1 | 2015 | 39 | 0.030 |
Why?
|
| Academic Medical Centers | 1 | 1997 | 318 | 0.030 |
Why?
|
| Disease Models, Animal | 1 | 2026 | 4660 | 0.030 |
Why?
|
| Optical Imaging | 1 | 2015 | 75 | 0.030 |
Why?
|
| Free Tissue Flaps | 1 | 2015 | 49 | 0.030 |
Why?
|
| Middle Aged | 3 | 2014 | 28400 | 0.030 |
Why?
|
| Nuclear Receptor Coactivator 2 | 1 | 2015 | 147 | 0.030 |
Why?
|
| Myocytes, Cardiac | 1 | 2020 | 674 | 0.030 |
Why?
|
| Cells, Cultured | 1 | 2020 | 2905 | 0.030 |
Why?
|
| Inflammation | 1 | 2020 | 1473 | 0.020 |
Why?
|
| United States | 5 | 1997 | 11828 | 0.020 |
Why?
|
| Cell Proliferation | 1 | 2020 | 2479 | 0.020 |
Why?
|
| Cell Line | 1 | 2017 | 2579 | 0.020 |
Why?
|
| Skin | 1 | 2015 | 543 | 0.020 |
Why?
|
| Interviews as Topic | 1 | 2014 | 441 | 0.020 |
Why?
|
| Medicare | 2 | 1997 | 438 | 0.020 |
Why?
|
| Models, Biological | 1 | 2015 | 1389 | 0.020 |
Why?
|
| Patient Satisfaction | 1 | 2014 | 451 | 0.020 |
Why?
|
| Opportunistic Infections | 1 | 1990 | 71 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 2015 | 2106 | 0.020 |
Why?
|
| Transcription Factors | 1 | 2020 | 2452 | 0.020 |
Why?
|
| Organizational Affiliation | 1 | 1989 | 2 | 0.020 |
Why?
|
| Health Maintenance Organizations | 1 | 1989 | 17 | 0.020 |
Why?
|
| Fees, Medical | 1 | 1989 | 7 | 0.020 |
Why?
|
| Periaqueductal Gray | 1 | 1989 | 5 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2015 | 2919 | 0.020 |
Why?
|
| Schools, Medical | 1 | 1989 | 113 | 0.020 |
Why?
|
| Infection Control | 2 | 1987 | 161 | 0.020 |
Why?
|
| History, 18th Century | 1 | 1988 | 69 | 0.020 |
Why?
|
| History, 19th Century | 1 | 1988 | 111 | 0.020 |
Why?
|
| Heart, Artificial | 2 | 1978 | 46 | 0.020 |
Why?
|
| Health Services Accessibility | 1 | 2014 | 693 | 0.020 |
Why?
|
| Europe | 1 | 1988 | 366 | 0.020 |
Why?
|
| Eye Diseases | 1 | 1989 | 108 | 0.020 |
Why?
|
| Clostridium perfringens | 1 | 1986 | 5 | 0.020 |
Why?
|
| Fusobacterium Infections | 1 | 1986 | 9 | 0.010 |
Why?
|
| Brain Diseases | 1 | 1989 | 300 | 0.010 |
Why?
|
| Jugular Veins | 1 | 1986 | 74 | 0.010 |
Why?
|
| Coronary Disease | 2 | 1978 | 628 | 0.010 |
Why?
|
| Influenza A virus | 1 | 1984 | 142 | 0.010 |
Why?
|
| Diagnosis, Differential | 1 | 1989 | 1889 | 0.010 |
Why?
|
| Kidney Transplantation | 2 | 1978 | 562 | 0.010 |
Why?
|
| Picornaviridae Infections | 1 | 1982 | 50 | 0.010 |
Why?
|
| Heart Transplantation | 2 | 1978 | 825 | 0.010 |
Why?
|
| Sepsis | 1 | 1986 | 496 | 0.010 |
Why?
|
| Interferons | 1 | 1982 | 136 | 0.010 |
Why?
|
| Thrombosis | 1 | 1986 | 495 | 0.010 |
Why?
|
| Cambodia | 1 | 1979 | 15 | 0.010 |
Why?
|
| Acute Disease | 2 | 1980 | 1151 | 0.010 |
Why?
|
| Refugees | 1 | 1979 | 39 | 0.010 |
Why?
|
| Drug Administration Schedule | 1 | 1980 | 731 | 0.010 |
Why?
|
| Assisted Circulation | 1 | 1978 | 22 | 0.010 |
Why?
|
| Intra-Aortic Balloon Pumping | 1 | 1978 | 39 | 0.010 |
Why?
|
| Veterans | 1 | 1989 | 1792 | 0.010 |
Why?
|
| Child | 3 | 1987 | 26168 | 0.010 |
Why?
|
| Cardiovascular Physiological Phenomena | 1 | 1976 | 28 | 0.010 |
Why?
|
| Guideline Adherence | 1 | 1997 | 391 | 0.010 |
Why?
|
| Faculty, Medical | 1 | 1997 | 279 | 0.010 |
Why?
|
| Practice Patterns, Physicians' | 1 | 1997 | 771 | 0.010 |
Why?
|
| Internship and Residency | 1 | 1997 | 1215 | 0.000 |
Why?
|
| Transplantation, Homologous | 2 | 1978 | 669 | 0.000 |
Why?
|
| Mitral Valve | 2 | 1978 | 246 | 0.000 |
Why?
|
| Postoperative Complications | 1 | 1978 | 3118 | 0.000 |
Why?
|
| Heart Valve Prosthesis | 2 | 1978 | 302 | 0.000 |
Why?
|
| Aortic Valve | 2 | 1978 | 456 | 0.000 |
Why?
|
| Drug Evaluation | 1 | 1982 | 101 | 0.000 |
Why?
|
| Aerosols | 1 | 1982 | 58 | 0.000 |
Why?
|
| Rhinovirus | 1 | 1982 | 66 | 0.000 |
Why?
|
| Nasal Cavity | 1 | 1982 | 57 | 0.000 |
Why?
|
| Contracture | 1 | 1978 | 26 | 0.000 |
Why?
|
| Double-Blind Method | 1 | 1982 | 1630 | 0.000 |
Why?
|
| Muscle Contraction | 1 | 1978 | 146 | 0.000 |
Why?
|
| Blood Coagulation Disorders | 1 | 1978 | 104 | 0.000 |
Why?
|
| Heart Valve Diseases | 1 | 1978 | 167 | 0.000 |
Why?
|
| Endocarditis, Bacterial | 1 | 1978 | 128 | 0.000 |
Why?
|
| Cardiopulmonary Bypass | 1 | 1978 | 358 | 0.000 |
Why?
|
| Statistics as Topic | 1 | 1976 | 239 | 0.000 |
Why?
|
| Adolescent | 2 | 1986 | 20762 | 0.000 |
Why?
|
| Heart Conduction System | 1 | 1976 | 161 | 0.000 |
Why?
|
| Syndrome | 1 | 1978 | 1160 | 0.000 |
Why?
|
| Blood Flow Velocity | 1 | 1976 | 418 | 0.000 |
Why?
|
| Heart Ventricles | 1 | 1978 | 757 | 0.000 |
Why?
|
| Kidney | 1 | 1978 | 1283 | 0.000 |
Why?
|
| Blood Pressure | 1 | 1976 | 1337 | 0.000 |
Why?
|
| Infant | 1 | 1986 | 13269 | 0.000 |
Why?
|
| Child, Preschool | 1 | 1986 | 14986 | 0.000 |
Why?
|
| Cardiovascular Diseases | 1 | 1976 | 2111 | 0.000 |
Why?
|